This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hou, D. Articles by March, K. L. Search for Related Content PubMed PubMed Citation Articles by Hou, D. Articles by March, K. L. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB 8-HYDROXYQUINOLINE Medline Plus Health Information Heart Attack Related Collections Animal models of human disease Other Treatment Acute myocardial infarction

(Circulation. 2005;112:I-150 – I-156.)
© 2005 American Heart Association, Inc.

Cell Transplantation and Tissue Engineering

Radiolabeled Cell Distribution After Intramyocardial, Intracoronary, and Interstitial Retrograde Coronary Venous Delivery

Implications for Current Clinical Trials

Dongming Hou, MD, PhD; Eyas Al-Shaykh Youssef, MD; Todd J. Brinton, MD; Ping Zhang, MD; Pamela Rogers, LATG; Erik T. Price, MD; Alan C. Yeung, MD; Brian H. Johnstone, PhD; Paul G. Yock, MD; Keith L. March, MD, PhD

From the Indiana University School of Medicine (D.H., E.A.-S.Y., P.Z., P.R., B.H.J., K.L.M.), the Krannert Institute of Cardiology (D.H., E.A.-S.Y., B.H.J., K.L.M.), and the Richard L. Roudebush VA Medical Center (K.L.M.), Indianapolis, Ind, and Stanford University School of Medicine (T.J.B., E.T.P., A.C.Y., P.G.Y.), Stanford, Calif.

Correspondence to Keith L. March, MD, PhD, Indiana Center for Vascular Biology and Medicine, 975 W Walnut St, IB 441, Indianapolis, IN 46202. E-mail kmarch{at}iupui.edu

Background— Several clinical studies are evaluating the therapeutic potential of delivery of various progenitor cells for treatment of injured hearts. However, the actual fate of delivered cells has not been thoroughly assessed for any cell type. We evaluated the short-term fate of peripheral blood mononuclear cells (PBMNCs) after intramyocardial (IM), intracoronary (IC), and interstitial retrograde coronary venous (IRV) delivery in an ischemic swine model.

Methods and Results— Myocardial ischemia was created by 45 minutes of balloon occlusion of the left anterior descending coronary artery. Six days later, 10^{7 111}indium-oxine–labeled human PBMNCs were delivered by IC (n=5), IM (n=6), or IRV (n=5) injection. The distribution of injected cells was assessed by -emission counting of harvested organs. For each delivery method, a significant fraction of delivered cells exited the heart into the pulmonary circulation, with 26±3% (IM), 47±1% (IC), and 43±3% (IRV) of cells found localized in the lungs. Within the myocardium, significantly more cells were retained after IM injection (11±3%) compared with IC (2.6±0.3%) (P<0.05) delivery. IRV delivery efficiency (3.2±1%) trended lower than IM infusion for PBMNCs, but this difference did not reach significance. The IM technique displayed the greatest variability in delivery efficiency by comparison with the other techniques.

Conclusions— The majority of delivered cells is not retained in the heart for each delivery modality. The clinical implications of these findings are potentially significant, because cells with proangiogenic or other therapeutic effects could conceivably have effects in other organs to which they are not primarily targeted but to which they are distributed. Also, we found that although IM injection was more efficient, it was less consistent in the delivery of PBMNCs compared with IC and IRV techniques.

Key Words: cells • ischemia • myocardial infarction • catheters

This article has been cited by other articles:

				D. P Sieveking and M. K. Ng Cell therapies for therapeutic angiogenesis: back to the bench Vascular Medicine, May 1, 2009; 14(2): 153 - 166. [Abstract] [PDF]

				V. Schachinger, A. Aicher, N. Dobert, R. Rover, J. Diener, S. Fichtlscherer, B. Assmus, F. H. Seeger, C. Menzel, W. Brenner, et al. Pilot Trial on Determinants of Progenitor Cell Recruitment to the Infarcted Human Myocardium Circulation, September 30, 2008; 118(14): 1425 - 1432. [Abstract] [Full Text] [PDF]